Atossa Genetics (NASDQ: ATOS) is a clinical-stage drug company developing novel, proprietary therapeutics and delivery methods for breast cancer and other breast conditions.
Visit our YouTube channel to learn more about Atossa Genetics.
Atossa Genetics Announces Second Quarter 2018 Financial Results And Provides Company Update
Atossa Genetics Contracts with Additional Manufacturer of Endoxifen
Atossa Genetics Announces Intraductal Microcatheter ImmunoOncology Pre-Clinical Program
More Press Releases
Learn more about Atossa Genetics
Learn more about our programs
Contact Atossa Genetics today!